Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $120.95bn | 30.41 | n/a |
REGNRegeneron Pharmaceuticals | $115.81bn | 29.9 | n/a |
MRNAModerna | $45.51bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $38.52bn | 27.45 | n/a |
ALNYAlnylam Pharmaceuticals | $30.74bn | n/a | n/a |
ICLRIcon | $25.92bn | 34.66 | n/a |
BNTXBioNTech SE | $19.10bn | 149.42 | n/a |
ASNDAscendis Pharma A/S | $15.88bn | n/a | n/a |
SRPTSarepta Therapeutics | $14.93bn | n/a | n/a |
UTHRUnited Therapeutics | $14.13bn | 15.04 | n/a |
NBIXNeurocrine Biosciences | $13.85bn | 37.44 | n/a |
MEDPMedpace Holdings | $12.76bn | 41.97 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
TECHBIO-TECHNE | $11.29bn | 53.34 | 0.45% |
INSMInsmed | $10.93bn | n/a | n/a |
CRLCharles River Laboratories International | $10.64bn | 22.12 | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
QGENQiagen NV | $9.20bn | 25.13 | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |